
Preclinical testing at The Ohio State University found Telomir-Zn inhibited growth of canine and human osteosarcoma cell lines, prompting the company to explore a possible in-vivo study in dogs with naturally occurring tumors.
The dosage for zinc (elemental) was listed incorrectly in Table 2 of this article.
In Table 2 of the article "Diagnosing and treating canine copper-associated hepatopathies" (August 2008), the dosage given for zinc (elemental) was incorrect. The dosage should have appeared as follows:
Table 2
Treating Canine Copper Hepatopathy
Drug
Dosage
Zinc (elemental)
5-10 mg/kg PO every 12 hours
We regret any confusion this may have caused.





